Anxiolytics

On this page

Anxiolytics Overview - Calm Keepers Intro

  • Anxiolytics: Drugs that reduce anxiety, fear, tension, and associated psychological distress.
  • Therapeutic Aim: Alleviate symptoms, improve daily functioning, and enhance overall quality of life.
  • Major Classes:
    • Benzodiazepines (BZDs): e.g., Diazepam, Lorazepam. Rapid onset for acute anxiety.
    • SSRIs/SNRIs: e.g., Escitalopram, Venlafaxine. First-line for most chronic anxiety disorders.
    • Buspirone: 5-HT1A partial agonist. Gradual onset, non-sedating, low abuse potential.
    • Beta-blockers: e.g., Propranolol. Manage performance anxiety, somatic symptoms (palpitations, tremors).

⭐ Benzodiazepines (BZDs) enhance GABA-A receptor function by increasing the frequency of chloride channel opening, distinct from barbiturates which increase duration. 📌 BZDs increase Frequency (BF Goodrich).

Benzodiazepines - GABA's Best Friends

  • MoA: Positive allosteric modulators at GABA-A receptors. Bind to specific BZD site, ↑ frequency of $Cl^-$ channel opening $ ightarrow$ potentiate GABA's inhibitory effect.
Loading diagram…
  • Actions: Anxiolytic, sedative-hypnotic, anticonvulsant, muscle relaxant, anterograde amnesia.
  • Kinetics:
    • Metabolized in liver.
    • 📌 LOT (Lorazepam, Oxazepam, Temazepam) undergo extrahepatic glucuronidation (safer in liver disease/elderly).
  • Uses: Anxiety (GAD, panic), insomnia, seizures (status epilepticus: Diazepam, Lorazepam IV), alcohol withdrawal, muscle spasms.
  • Adverse Effects: Drowsiness, ataxia, dependence, tolerance, withdrawal. Respiratory depression with other CNS depressants.
  • Antidote: Flumazenil (BZD antagonist).

    ⭐ Flumazenil can precipitate seizures in BZD-dependent patients or those on tricyclic antidepressants.

SSRIs & SNRIs - Serotonin Soothers

  • First-line for GAD, panic, social anxiety, PTSD, OCD. Preferred for long-term management.
  • Mechanism: Block reuptake of serotonin (SSRIs) or serotonin & norepinephrine (SNRIs).
  • Examples:
    • SSRIs: Fluoxetine, Sertraline, Paroxetine, Escitalopram.
    • SNRIs: Venlafaxine, Duloxetine.
  • Advantages vs BZDs: No dependence/abuse, treats comorbid depression, better safety.
  • Delayed anxiolytic onset: 2-4 weeks; full effect may take 6-8 weeks.
  • Side effects: GI upset, headache, sexual dysfunction. Initial anxiety ↑ possible.

⭐ Paroxetine has a shorter half-life among SSRIs, leading to higher risk of discontinuation syndrome.

Other Anxiolytics - The Eclectic Mix

  • Buspirone
    • Mechanism: 5-HT1A partial agonist.
    • Use: Generalized Anxiety Disorder (GAD).
    • Onset: Slow (2-4 weeks); no sedation/dependence.
  • Propranolol
    • Mechanism: Beta-blocker.
    • Use: Performance anxiety, akathisia.
  • Hydroxyzine
    • Mechanism: Antihistamine (H1 blocker).
    • Use: Short-term anxiety, pruritus; sedative effects.
  • Pregabalin
    • Mechanism: Modulates voltage-gated $Ca^{2+}$ channels (α2δ ligand).
    • Use: GAD, neuropathic pain.

⭐ Buspirone lacks anticonvulsant, muscle relaxant, and significant sedative effects, distinguishing it from benzodiazepines; it does not cause withdrawal symptoms or abuse potential.

High‑Yield Points - ⚡ Biggest Takeaways

  • Benzodiazepines (BZDs) enhance GABA-A receptor function, ↑ Cl- influx; Flumazenil is the antidote.
  • Buspirone, a 5-HT1A partial agonist, is a non-sedating anxiolytic with delayed onset of action.
  • SSRIs/SNRIs are first-line for most chronic anxiety disorders (e.g., GAD, panic disorder).
  • Beta-blockers (e.g., Propranolol) manage performance anxiety by reducing somatic symptoms.
  • BZDs carry risks of tolerance, dependence, and withdrawal; preferred for short-term use.
  • Short-acting BZDs (Lorazepam, Oxazepam, Temazepam - LOT) are safer in elderly/liver disease due to metabolism by glucuronidation outside the liver primarily (Oxazepam, Temazepam) or simpler metabolism (Lorazepam).

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Anxiolytics

  1. 1. Which receptor is primarily blocked by typical antipsychotics to produce their therapeutic effect?

    • A. 5HT4 serotonergic
    • B. D1 dopaminergic
    • C. Muscarinic
    • D. D2 dopaminergic
    Show answer

    Answer: D. D2 dopaminergic

    > Key point: Typical antipsychotics produce their main therapeutic effect by blocking D2 dopaminergic receptors. Why D2 dopaminergic is correct - D2 blockade is the principal therapeutic receptor action of typical antipsychotics. - In mesolimbic pathways, this blockade reduces positive psychotic symptoms. How they compare | Receptor | Role here | |---|---| | D2 dopaminergic | Principal therapeutic target | | Muscarinic | Blockade contributes anticholinergic adverse effects | | D1 dopaminergic | Not the principal therapeutic target | | 5HT4 serotonergic | Not the principal therapeutic target | Why the other options are wrong - Muscarinic: Blockade chiefly contributes anticholinergic adverse effects, not the main therapeutic effect. - D1 dopaminergic: It is not the principal therapeutic receptor target. - 5HT4 serotonergic: It is not the principal therapeutic receptor target.

  2. 2. Which sympathomimetic increases heart rate through β1 stimulation and produces β2-mediated vasodilation without α-receptor stimulation?

    • A. Phenylephrine
    • B. Noradrenaline
    • C. Isoprenaline
    • D. Adrenaline
    Show answer

    Answer: C. Isoprenaline

    > Key point: Isoprenaline stimulates β1 and β2 receptors without α-receptor stimulation. Why Isoprenaline is correct - Its β1 stimulation increases heart rate, while β2 stimulation produces vasodilation. - It has no α-receptor stimulation, matching all parts of the stem. How they compare | Drug | Receptor profile | Why it fits or fails | |---|---|---| | Isoprenaline | β1, β2 | Raises heart rate and causes β2-mediated vasodilation; no α activity | | Adrenaline | α1, β1, β2 | Has α-receptor activity | | Noradrenaline | Mainly α1; some β1 | Lacks the stated β2-mediated vasodilation profile | | Phenylephrine | α1 | Has α activity and does not match the β1/β2 profile | Why the other options are wrong - Adrenaline: stimulates α receptors as well as β1 and β2. - Noradrenaline: predominantly stimulates α1 and has some β1 activity, not the stated β1/β2 profile without α activity. - Phenylephrine: is an α1 agonist, not a β1/β2 agonist.

  3. 3. Which drug class provides rapid symptomatic relief of an acute panic attack in an adult?

    • A. MAO inhibitors
    • B. Tricyclic antidepressants
    • C. Barbiturates
    • D. Benzodiazepines
    Show answer

    Answer: D. Benzodiazepines

    > Key point: Benzodiazepines provide rapid symptomatic relief during an acute panic attack. Why Benzodiazepines is correct - They enhance GABA-A receptor-mediated inhibition and can relieve acute panic symptoms rapidly. - Sedation and dependence limit their continued use. How they compare | Drug class | Role in panic symptoms | Timing or limitation | |---|---|---| | Benzodiazepines | Rapid acute relief | Sedation and dependence limit continued use | | Tricyclic antidepressants | Prevent recurrent attacks | Delayed therapeutic onset | | MAO inhibitors | Treat panic disorder | Benefit takes weeks | | Barbiturates | Not routine treatment | Narrow therapeutic index; respiratory depression risk | Why the other options are wrong - Tricyclic antidepressants: Their delayed onset makes them unsuitable for rapid relief during an acute attack. - MAO inhibitors: They may treat panic disorder, but take weeks to provide therapeutic benefit. - Barbiturates: Their safety risks make them unsuitable for routine acute treatment.

  4. 4. Which anti-epileptic drug marked X will act at the site shown?

    • A. Tiagabine
    • B. Vigabatrin
    • C. Valproate
    • D. Gabapentin
    Show answer

    Answer: A. Tiagabine

    > Key point: Tiagabine inhibits GABA reuptake from the synaptic cleft. Why Tiagabine is correct - The marked site is GABA reuptake, and tiagabine inhibits this transport. - This increases GABA available in the synapse and enhances inhibitory neurotransmission. How they compare | Drug | Relevant action | |---|---| | Tiagabine | Inhibits GABA reuptake | | Valproate | Inhibits GABA transaminase; also affects ion channels | | Gabapentin | Binds the α2δ subunit of voltage-gated calcium channels | | Vigabatrin | Irreversibly inhibits GABA transaminase | Why the other options are wrong - Valproate: increases GABA partly by inhibiting its breakdown, rather than blocking reuptake at the marked site. - Gabapentin: acts at voltage-gated calcium channels, not the GABA reuptake mechanism. - Vigabatrin: inhibits GABA breakdown enzymatically rather than blocking its reuptake.

  5. 5. Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?

    • A. Zolpidem
    • B. Phenobarbital
    • C. Diazepam
    • D. Buspirone
    Show answer

    Answer: D. Buspirone

    > Key point: Buspirone is a 5-HT1A partial agonist without significant anticonvulsant or muscle-relaxant effects. Why Buspirone is correct - It acts primarily as a 5-HT1A receptor partial agonist. - Unlike benzodiazepines, it lacks significant anticonvulsant and muscle-relaxant properties. How they compare | Drug | Main mechanism or profile | |---|---| | Buspirone | 5-HT1A partial agonist; lacks significant anticonvulsant and muscle-relaxant effects | | Diazepam | GABA-A activity; anticonvulsant and muscle-relaxant effects | | Zolpidem | GABA-A activity; primarily a hypnotic | | Phenobarbital | GABA-A activity; sedative and anticonvulsant effects | Why the other options are wrong - Diazepam: Its GABA-A effects include anticonvulsant and muscle-relaxant actions. - Zolpidem: It acts at GABA-A receptors and is primarily a hypnotic, not a 5-HT1A partial agonist. - Phenobarbital: Its GABA-A effects and anticonvulsant action do not fit the described profile.

  6. 6. A patient on nitroprusside therapy developed cyanide toxicity. Sodium nitrite was administered intravenously to combat this poisoning. The beneficial effect of sodium nitrite in this case is dependent on which of the following mechanisms?

    • A. Direct cyanide chelation
    • B. Methemoglobin formation
    • C. Peripheral vasodilation
    • D. Cyanocobalamin formation
    Show answer

    Answer: B. Methemoglobin formation

    > Key point: Sodium nitrite treats cyanide toxicity by forming methemoglobin, which binds cyanide. Why Methemoglobin formation is correct - Sodium nitrite oxidizes hemoglobin to methemoglobin. - Methemoglobin binds cyanide, sequestering it away from cytochrome oxidase. Why the other options are wrong - Direct cyanide chelation: Sodium nitrite does not directly bind cyanide; methemoglobin provides the binding site. - Peripheral vasodilation: This may occur with nitrites but does not neutralize cyanide. - Cyanocobalamin formation: Hydroxocobalamin, not sodium nitrite, binds cyanide to form cyanocobalamin.

  7. 7. Which of the following is a tertiary-amine tricyclic antidepressant?

    • A. Citalopram
    • B. Amitriptyline
    • C. Nortriptyline
    • D. Desvenlafaxine
    Show answer

    Answer: B. Amitriptyline

    > Key point: Amitriptyline is a tertiary-amine tricyclic antidepressant. Why Amitriptyline is correct - Amitriptyline is a tertiary-amine TCA, matching both parts of the description. How they compare | Drug | Class | Amine type | |---|---|---| | Amitriptyline | TCA | Tertiary | | Citalopram | SSRI | Not a TCA | | Desvenlafaxine | SNRI | Not a TCA | | Nortriptyline | TCA | Secondary | Why the other options are wrong - Citalopram: It is an SSRI, not a tricyclic antidepressant. - Desvenlafaxine: It is an SNRI, not a tricyclic antidepressant. - Nortriptyline: It is a TCA, but is secondary-amine rather than tertiary-amine.

  8. 8. Which of the following poisons does NOT characteristically increase the osmolar gap?

    • A. Methyl alcohol
    • B. Acetaminophen
    • C. Dimethyl ketone
    • D. Ethylene glycol
    Show answer

    Answer: B. Acetaminophen

    > Key point: Toxic alcohols and acetone can raise the osmolar gap; acetaminophen does not characteristically do so. Why Acetaminophen is correct - Acetaminophen is not an osmotically active alcohol or small molecule that typically accumulates enough in plasma to raise the osmolar gap. - Its major toxicity is liver injury from NAPQI, not an increased osmolar gap. How they compare | Poison | Osmolar gap | |---|---| | Acetaminophen | Not characteristically increased | | Methyl alcohol | Increased | | Dimethyl ketone | Increased | | Ethylene glycol | Increased | Why the other options are wrong - Methyl alcohol: The parent alcohol can accumulate in plasma and raise the osmolar gap. - Dimethyl ketone: This small molecule can accumulate in blood and raise the osmolar gap. - Ethylene glycol: The parent compound can accumulate in plasma and raise the osmolar gap.

  9. 9. What is the primary therapeutic use of 5-HT1B/1D agonists?

    • A. Acute migraine
    • B. Chemotherapy-induced nausea and vomiting
    • C. Generalized anxiety disorder
    • D. Gastroesophageal reflux disease
    Show answer

    Answer: A. Acute migraine

    > Key point: 5-HT1B/1D agonists, including triptans, are used to treat acute migraine attacks. Why Acute migraine is correct - Triptans activate 5-HT1B/1D receptors and help relieve acute migraine symptoms. - Their effects include cranial vasoconstriction and inhibition of pro-inflammatory neuropeptide release. Why the other options are wrong - Gastroesophageal reflux disease: GERD is treated with acid-reducing or acid-neutralizing therapies, not 5-HT1B/1D agonists. - Generalized anxiety disorder: 5-HT1B/1D agonists are not used as anxiolytics. - Chemotherapy-induced nausea and vomiting: This is treated with 5-HT3 antagonists, not 5-HT1B/1D agonists.

  10. 10. Which listed SSRI generally has the lowest potential for clinically significant CYP-mediated pharmacokinetic interactions at usual therapeutic doses?

    • A. Fluvoxamine
    • B. Paroxetine
    • C. Fluoxetine
    • D. Sertraline
    Show answer

    Answer: D. Sertraline

    > Key point: Sertraline generally has the lowest potential for clinically significant CYP-mediated interactions among these choices at usual therapeutic doses. Why Sertraline is correct - Its overall CYP-mediated interaction potential is generally lower than that of the other listed SSRIs at usual therapeutic doses. - It can still inhibit CYP2D6, so interactions remain possible with susceptible drugs. How they compare | SSRI | Main interaction concern | |---|---| | Sertraline | Lowest overall potential here; can inhibit CYP2D6 | | Fluvoxamine | Strong inhibition of CYP1A2 and CYP2C19 | | Paroxetine | Potent CYP2D6 inhibition | | Fluoxetine | Potent CYP2D6 inhibition; long-lasting interaction risk | Why the other options are wrong - Fluvoxamine: Its strong CYP1A2 and CYP2C19 inhibition gives it greater interaction potential. - Paroxetine: Potent CYP2D6 inhibition can raise concentrations of susceptible drugs. - Fluoxetine: Potent CYP2D6 inhibition and its long half-life with an active metabolite can prolong interactions.

Flashcards: Anxiolytics

  1. 1. Long-acting _____ are useful in the treatment of _____ withdrawal (if no cirrhosis or _____ hepatitis)

    Show answer

    benzodiazepines · alcohol · alcoholic

  2. 2. Main mechanism of antidepressant action is to change the neurotransmitter

    Show answer

    receptor sensitivity

  3. 3. Tricyclic antidepressant having additional dopaminergic D2 receptor _____ action is _____.

    Show answer

    antagonist · amoxapine

  4. 4. Mirtazapine is an _____-adrenergic antagonist, which increases pre-synaptic release of _____ and _____

    Show answer

    alpha-2 · serotonin · norepinephrine

  5. 5. is associated with a higher risk of weight gain than any other SSRI.

    Show answer

    Paroxetine

  6. 6. Which SSRI has the least risk of causing drug-discontinuation symptoms?

    Show answer

    Fluoxetine

  7. 7. Discontinuation syndrome, consisting of agitation, anxiety and insomnia has been characteristically reported with stopping

    Show answer

    venlafaxine

  8. 8. Neuro/Psych _____ is an anti-epileptic associated with blood dyscrasias, such as _____ and _____

    Show answer

    Carbamazepine · aplastic anemia · agranulocytosis

  9. 9. Neuro/Psych_____ is a competitive antagonist at the _____ of the _____ receptor, which is used to treat overdose or reverse sedative effects of _____

    Show answer

    Flumazenil · benzodiazepine site · GABA-A · benzodiazepines AND nonbenzodiazepine hypnotics

  10. 10. Typical antipsychotics are associated with anti-cholinergic effects, such as _____ and _____

    Show answer

    dry mouth · constipation

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF